SCHEMBL9459976

SCHEMBL9459976

N#CC1=CCCCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8566623 0.86
SCHEMBL6068446 0.79
SCHEMBL28376827 0.77
SCHEMBL20439663 0.75
SCHEMBL11902985 0.71 MAPT (0.33)
SCHEMBL24514891 0.68
SCHEMBL7548678 0.68 NAMPT (0.31)
SCHEMBL11502520 0.67 MAPT (0.41)
SCHEMBL149920 0.65
SCHEMBL9613600 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190224214-A1 HUMAN GHRELIN O-ACYLTRANSFERASE INHIBITORS SYRACUSE UNIVERSITY (US) 2019-07-25 US disclosed
WO-2018035079-A1 HUMAN GHRELIN O-ACYL TRANSFERASE INHIBITORS HOUGLAND JAMES L (US) 2018-02-22 WO disclosed
US-5194650-A Chemical intermediates which can be hydrolyzed to form arylcyclohexadionethiocarboxylic S-ester as bioregulators BASF AKTIENGESELLSCHAFT (DE) 1993-03-16 US disclosed
US-5130453-A Multistage reaction of acylcyclohexadione, reaction with hydroxylamine derivative and mercaptan BASF AKTIENGESELLSCHAFT (DE) 1992-07-14 US disclosed
US-5085689-A Preemergence and postemergence treatment BASF AKTIENGESELLSCHAFT (DE) 1992-02-04 US disclosed